Sanders Morris Harris’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sanders Morris Harris’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,600	Closed	-$681K	–	174
2026 Q1	$681K	Buy	+3,600	New	+$629K	0.11%	157
2025 Q4	–	Sell	-3,600	Closed	-$474K	–	161
2025 Q3	$474K	Buy	+3,600	New	+$432K	0.06%	174
2025 Q2	–	Sell	-3,600	Closed	-$450K	–	230
2025 Q1	$450K	Hold	3,600	–	–	0.07%	168
2024 Q4	$443K	Hold	3,600	–	–	0.07%	176
2024 Q3	$401K	Hold	3,600	–	–	0.07%	179
2024 Q2	$384K	Hold	3,600	–	–	0.06%	187
2024 Q1	$434K	Hold	3,600	–	–	0.08%	171
2023 Q4	$450K	Hold	3,600	–	–	0.22%	121
2023 Q3	$463K	Hold	3,600	–	–	0.1%	160
2023 Q2	$447K	Buy	+3,600	New	+$484K	0.1%	154
2023 Q1	–	Sell	-3,600	Closed	-$574K	–	199
2022 Q4	$574K	Hold	3,600	–	–	0.22%	104
2022 Q3	$487K	Buy	+3,600	New	+$547K	0.12%	138
2022 Q1	–	Sell	-3,600	Closed	-$470K	–	323
2021 Q4	$470K	Hold	3,600	–	–	0.08%	176
2021 Q3	$504K	Hold	3,600	–	–	0.09%	164
2021 Q2	$659K	Sell	3,600 -100	-3%	-$17.3K	0.13%	134
2021 Q1	$599K	Hold	3,700	–	–	0.13%	128
2020 Q4	$603K	Hold	3,700	–	–	0.14%	132
2020 Q3	$562K	Buy	+3,700	New	+$459K	0.15%	124

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Sanders Morris Harris's JAZZ Position: Q2 2026 in Review

Sanders Morris Harris sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 3,600 shares — an estimated $681K sold.

Sanders Morris Harris first reported a position in JAZZ in Q3 2020 and held it in 18 quarters. The position peaked at $681K in Q1 2026. 86 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Sanders Morris Harris reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sanders Morris Harris sold 3,600 Jazz Pharmaceuticals shares in Q2 2026, an estimated $681K.
Sanders Morris Harris first reported a position in Jazz Pharmaceuticals in Q3 2020 and held it in 18 quarters.
Sanders Morris Harris's Jazz Pharmaceuticals position peaked at $681K in Q1 2026.
86 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.